Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 39 - Medicinal preparations containing antigens or antibodies
Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
11/2007
11/01/2007US20070253966 Fusion Proteins
11/01/2007US20070253965 Reagents for Diagnosis and Therapy of Latex Allergy and Method for the Preparation of the Same
11/01/2007US20070253964 Novel Immunogenic Compositions for the Prevention and Treatment of Meningococcal Disease
11/01/2007US20070253963 Epithelial cell specific growth factor keratinocyte growth factor (KGF)
11/01/2007US20070253962 Immunomodulation of inflammatory conditions utilizing follistatin-like protein-1 and agents that bind thereto
11/01/2007US20070253961 Pharmaceutical Composition Comprising the Anti-4-1Bb Antibody for Treating or Preventing Rheumatoid Arthritis
11/01/2007US20070253960 Pharmaceutical removal of vascular extensions from a degenerating disc
11/01/2007US20070253959 Vascular endothelial cell growth factor antagonists
11/01/2007US20070253958 Human monoclonal antibodies to FC gamma receptor II (CD32)
11/01/2007US20070253957 Substituted N-Aryl-1H-Pyrazolo[3,4-B]Quinolin-4-Amines and Analogs as Activators of Caspases and Inducers of Apoptosis
11/01/2007US20070253956 Method for opening tight junctions
11/01/2007US20070253955 Methods for altering fertility
11/01/2007US20070253954 Epha4 As Therapeutic Target Of Prc And Pdaca
11/01/2007US20070253953 Molecular Signature of the Pten Tumor Suppressor
11/01/2007US20070253952 Multifunctional and Multivalent Angiogenesis Inhibitors
11/01/2007US20070253951 Humanized c-Kit antibody
11/01/2007US20070253950 Methods for Preventing and Treating Amyloidogenic Diseases
11/01/2007US20070253949 Diagnostics and Therapeutics for Diseases Associated with Plasma Kallikrein (KLKB1)
11/01/2007US20070253948 Anti-FC-gamma RIIB receptor antibody and uses therefor
11/01/2007US20070253947 Immunogen adherence inhibitor directed to lactic acid producing organisms and method of making and using it
11/01/2007US20070253946 Axon Regeneration Promoter
11/01/2007US20070253936 Self-complementary parvoviral vectors, and methods for making and using the same
11/01/2007US20070253935 Surface expression method of peptides p5 and anal3 using the gene encoding poly-gamma-glutamate synthetase
11/01/2007US20070253933 Carotene Synthase Gene and Uses Therefor
11/01/2007US20070253931 Use of mesenchymal stem cells for treating genetic diseases and disorders
11/01/2007US20070253928 Pharmaceutical removal of neuronal extensions from a degenerating disc
11/01/2007US20070253904 administering a diabetic patient a formulation containing an aryl hydrocarbon receptor nuclea rtranslocator (ARNT) polypeptide to treat diabetes type I, diabetes type II, impaired glucose tolerance, insulin resistance, and beta cell dysfunction
11/01/2007US20070253902 Treatment for inflammatory bowel disease
11/01/2007US20070253900 The 98P4B6 gene, its fragment, its encoded protein, variants , or a fragment, can be used to elicit a humoral or cellular immune response; antibodies or T cells reactive with 98P4B6 can be used in active or passive immunization
11/01/2007US20070253896 7,9-Dihydro-Purin-8-One and Related Analogs as HSP90-Inhibitors
11/01/2007CA2650699A1 Diagnostic agent and therapeutic agent for pancreatic cancer
11/01/2007CA2649912A1 Application of anti-apoptotic genes in mammalian cells for perfusion culture
11/01/2007CA2649751A1 Glp-1 compound/glucagon antibody compositions
11/01/2007CA2649631A1 Vaccine against nicotine addiction
11/01/2007CA2649538A1 Buffering agents for biopharmaceutical formulations
11/01/2007CA2649528A1 Therapeutic agent for allergy containing liposome having oligosaccharide on its surface
11/01/2007CA2649522A1 Medicaments
11/01/2007CA2649426A1 Recombinant attenuated clostridium organisms and vaccine
11/01/2007CA2649292A1 Lyophilized therapeutic peptibody formulations
11/01/2007CA2649037A1 Anti-factor xiia therapy
11/01/2007CA2647671A1 Treatment of tumors expressing mutant egf receptors
11/01/2007CA2646902A1 Cxcl13 antagonists and their use for the treatment of inflammatory diseases
11/01/2007CA2646319A1 Methods and compositions based on shiga toxin type 1 protein
11/01/2007CA2645832A1 Hcv vaccinations
10/2007
10/31/2007EP1849869A2 Nucleotide sequences of HIV-1 group (or sub-group) 0 retroviral antigens
10/31/2007EP1849860A2 Culture medium with yeast or soy bean extract as aminoacid source and no protein complexes of animal origin
10/31/2007EP1849802A2 Methods for altering fertility
10/31/2007EP1849800A2 Moraxella catarrhalis proteins
10/31/2007EP1849798A1 Cell permeable peptide
10/31/2007EP1849780A1 Vaccine against nicotine addiction
10/31/2007EP1849480A2 Compositions and methods for restoring sensitivity of tumor cells to antitumor therapy and inducing apoptosis
10/31/2007EP1849479A1 Ameliorating agent for symptoms resulting from joint diseases
10/31/2007EP1849478A2 Inflammatory mediator antagonists
10/31/2007EP1849477A1 Use of skin penetration enhancers and barrier disruption agents to enhance the transcutaneous immune response induced by ADP-ribosylating exotoxin
10/31/2007EP1848813A2 Bacterial glycolipid activation of cd1d-restricted nkt cells
10/31/2007EP1848806A1 Anti-t cell and autoantigen treatment of autoimmune disease
10/31/2007EP1848794A2 Compositions comprising dehydrated micro-organisms, method for preparing same, and uses thereof
10/31/2007EP1848743A2 Interleukin-17f antibodies and other il-17f signaling antagonists and uses therefor
10/31/2007EP1848742A1 Anti-prl-3 antibodies and methods of use thereof
10/31/2007EP1848741A1 Human monoclonal antibody specific for lipopolysaccharides (lps) of the pseudomonas aeruginosa iats o11 serotype
10/31/2007EP1848740A1 Monoclonal antibodies that bind or neutralize hepatitis b virus
10/31/2007EP1848739A2 Adamts-7 as a biomarker for cancers of epithelial origin
10/31/2007EP1848504A2 Wound treatment device for photodynamic therapy and method of using same
10/31/2007EP1848462A2 Methods for treating cancer using an immunotoxin comprising an exotoxin a moiety having a furin cleavage site replaced with a cancer-associated protease site cleaved by mmp-2 or mmp-9
10/31/2007EP1848457A2 Vaccines against neisseria meningitidis
10/31/2007EP1848456A2 Poly-epitope peptide derived from thymidylate synthase having immunological and anti-tumour activity
10/31/2007EP1848454A1 Methods for treating lymphomas using a combination of a chemotherapeutic agent and il-2 and optionally an anti-cd20 antibody
10/31/2007EP1848452A2 Use of nkg2d receptor/nkg2d ligand interaction blockers in the treatment of auto-immune diseases
10/31/2007EP1848398A1 Stabilization of viral compositions
10/31/2007EP1680446B1 Compositions comprising melittin-derived peptides and methods for the potentiation of immune responses against target antigens
10/31/2007EP1509606B1 Allergen from mugwort pollen
10/31/2007EP1372691B1 Mucin peptide with immunoenhancing properties
10/31/2007EP1214054B1 Intranasal influenza virus vaccine
10/31/2007EP1192247B9 Sphingosine kinase enzyme
10/31/2007EP1078004B1 Tetravalent antibody constructs
10/31/2007EP1012320B1 Use of multivalent chimeric peptide-loaded, mhc/ig molecules to detect, activate or suppress antigen-specific t cell-dependent immune responses
10/31/2007EP1012173B1 Isolated decapeptides which bind to hla molecules, and the use thereof
10/31/2007EP1011707B1 HIV-1 gp120 V1/V2 DOMAIN EPITOPES CAPABLE OF GENERATING NEUTRALIZING ANTIBODIES
10/31/2007EP0998576B1 Method for producing a recombinant bovine adenovirus vector
10/31/2007CN101065667A Methods of diagnosing and treating complications of pregnancy
10/31/2007CN101065666A Ileitis diagnostic assay
10/31/2007CN101065147A Naturally occurring IgM antibodies that bind lymphocytes
10/31/2007CN101065146A Method of preventive treatment of allergy by mucosal administration of an allergy vaccine
10/31/2007CN101065145A A chimeric G protein based rabies vaccine
10/31/2007CN101065144A Methods and compositions for treatment of hematologic cancers
10/31/2007CN101063142A Human papilloma virus 16 type DNA vaccine and gene adjuvant and its application
10/31/2007CN101063141A Moraxella(branhamella) catarrhalis antigens
10/31/2007CN101063116A Streptococcus pneumonia autoenzyme protein and its protocaryon expression purification technique and vaccine
10/31/2007CN101062951A Fusion protein exciting immunity generation of body to plague and its coding gene and application
10/31/2007CN101062949A Recombinant anti human IgE monoclonal antibody and preparation method and usage thereof
10/31/2007CN101062941A Recombined hepatitis E hepatitis virus protein, preparation method and usage thereof
10/31/2007CN101062415A Use of IL-18 inhibitors
10/31/2007CN101062414A Application of anti-intercellular adhesion molecule-1 monoclonal antibody for preparing medicine for treating avian influenza
10/31/2007CN101062413A Method for preparing anti-dog parvovirus egg yolk antibody biological preparation
10/31/2007CN101062412A Recombinant fowlpox vaccine virus rFPV-1218AIH9 and the constructing method and function
10/31/2007CN101062411A Method for producing influenza vaccine in large-scale by using bioreactor
10/31/2007CN101062410A Genetic engineering vaccine of enterohemorrhagic escherichia coli 0157:H7 and the preparing method thereof
10/31/2007CN101062409A Method for preparing poultry cholera microcapsule vaccine
10/31/2007CN101062035A Therapeutic combinations comprising amlodipin and atorvastatin
10/31/2007CN101062015A Urease epitope fusion peptide liposome bacterin for preventing the helicobacter pylori infecting
1 ... 811 812 813 814 815 816 817 818 819 820 821 822 823 824 825 826 827 828 829 830 831 ... 1823